Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
J Natl Cancer Inst
    July 2018
  1. DAVIS LYNN BC, Rosenberg PS, Anderson WF, Gierach GL, et al
    Black-White Breast Cancer Incidence Trends: Effects of Ethnicity.
    J Natl Cancer Inst. 2018 Jul 5. pii: 5049141. doi: 10.1093.
    >> Share

    June 2018
  2. LAMBERTINI M, Campbell C, Bines J, Korde LA, et al
    Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
    J Natl Cancer Inst. 2018 Jun 5. pii: 5033460. doi: 10.1093.
    >> Share

  3. CATHCART-RAKE E, Gast KC, Ruddy KJ
    What Can We Learn From Menstrual Patterns After Treatment for HER2-Positive Breast Cancer?
    J Natl Cancer Inst. 2018 Jun 5. pii: 5033462. doi: 10.1093.
    >> Share


  4. Corrigendum to "Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer".
    J Natl Cancer Inst. 2018;110:684.
    >> Share

    May 2018
  5. PATTERSON RE, Marinac CR, Sears DD, Kerr J, et al
    The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.
    J Natl Cancer Inst. 2018 May 18. pii: 4999668. doi: 10.1093.
    >> Share

  6. LOHMANN AE, Pimentel I, Goodwin PJ
    Novel Insights Into the Impact of Lifestyle-Based Weight Loss and Metformin on Obesity-Associated Biomarkers in Breast Cancer.
    J Natl Cancer Inst. 2018 May 18. pii: 4999672. doi: 10.1093.
    >> Share

    April 2018
  7. DESMEDT C, Demicheli R, Fornili M, Bachir I, et al
    Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.
    J Natl Cancer Inst. 2018 Apr 30. pii: 4975381. doi: 10.1093.
    >> Share

  8. JAYASEKERA J, Li Y, Schechter CB, Jagsi R, et al
    Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
    J Natl Cancer Inst. 2018 Apr 28. pii: 4990602. doi: 10.1093.
    >> Share

  9. BIDARD FC, Michiels S, Riethdorf S, Mueller V, et al
    Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
    J Natl Cancer Inst. 2018 Apr 12. pii: 4969338. doi: 10.1093.
    >> Share

  10. CHOI HJ, Joo HS, Won HY, Min KW, et al
    Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    J Natl Cancer Inst. 2018;110.
    >> Share

  11. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    >> Share

    March 2018
  12. MATIKAS A, Foukakis T, Bergh J
    RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018 Mar 29. pii: 4956469. doi: 10.1093.
    >> Share

  13. HAWK E, Maresso KC, Brown P
    NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question.
    J Natl Cancer Inst. 2018 Mar 15. pii: 4938606. doi: 10.1093.
    >> Share

  14. RITZWOLLER DP, Hassett MJ, Uno H, Cronin AM, et al
    Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.
    J Natl Cancer Inst. 2018;110:273-281.
    >> Share

    February 2018
  15. GAIL MH, Pfeiffer RM
    Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.
    J Natl Cancer Inst. 2018 Feb 27. pii: 4912416. doi: 10.1093.
    >> Share

  16. ZACHARIAE R, Amidi A, Damholdt MF, Clausen CDR, et al
    Internet-Delivered Cognitive-Behavioral Therapy for Insomnia in Breast Cancer Survivors: A Randomized Controlled Trial.
    J Natl Cancer Inst. 2018 Feb 20. pii: 4881759. doi: 10.1093.
    >> Share

  17. OESTERREICH S, Lucas PC, McAuliffe PF, Bruno TC, et al
    Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer.
    J Natl Cancer Inst. 2018 Feb 20. pii: 4881762. doi: 10.1093.
    >> Share

  18. DESMEDT C, Salgado R, Fornili M, Pruneri G, et al
    Immune Infiltration in Invasive Lobular Breast Cancer.
    J Natl Cancer Inst. 2018 Feb 20. pii: 4881757. doi: 10.1093.
    >> Share

  19. IRWIN MR
    Innovation in the Treatment of Insomnia in Breast Cancer Survivors.
    J Natl Cancer Inst. 2018 Feb 20. pii: 4881761. doi: 10.1093.
    >> Share

  20. BROWN J, Rathbone E, Hinsley S, Gregory W, et al
    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
    J Natl Cancer Inst. 2018 Feb 7. pii: 4842040. doi: 10.1093.
    >> Share

  21. HEINDL A, Sestak I, Naidoo K, Cuzick J, et al
    Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.
    J Natl Cancer Inst. 2018;110.
    >> Share

  22. TROESTER MA, Sun X, Allott EH, Geradts J, et al
    Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
    J Natl Cancer Inst. 2018;110.
    >> Share

  23. BANDOS H, Melnikow J, Rivera DR, Swain SM, et al
    Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
    J Natl Cancer Inst. 2018;110.
    >> Share

  24. RIVERA DR, Ganz PA, Weyrich MS, Bandos H, et al
    Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    >> Share

  25. JAGSI R, Momoh AO, Qi J, Hamill JB, et al
    Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction.
    J Natl Cancer Inst. 2018;110.
    >> Share

    January 2018
  26. LINDSTROM LS, Yau C, Czene K, Thompson CK, et al
    Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
    J Natl Cancer Inst. 2018 Jan 19. pii: 4780395. doi: 10.1093.
    >> Share

  27. OZTURK TOPCU T, Jerzak KJ, Warner E
    RE: Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
    J Natl Cancer Inst. 2018 Jan 10. pii: 4797407. doi: 10.1093.
    >> Share

  28. LASKY-SU JA, Zeleznik OA, Eliassen AH
    Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk.
    J Natl Cancer Inst. 2018 Jan 9. pii: 4795354. doi: 10.1093.
    >> Share

  29. MOORE SC, Playdon MC, Sampson JN, Hoover RN, et al
    A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.
    J Natl Cancer Inst. 2018 Jan 9. pii: 4795343. doi: 10.1093.
    >> Share

  30. SCHRIJVER WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, et al
    Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018 Jan 5. pii: 4791841. doi: 10.1093.
    >> Share

  31. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
    J Natl Cancer Inst. 2018;110.
    >> Share

  32. GOLDVASER H, Barnes TA, Seruga B, Cescon DW, et al
    Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018;110.
    >> Share

  33. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    >> Share

    December 2017
  34. POORVU PD, Winer EP
    Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway.
    J Natl Cancer Inst. 2017 Dec 11. pii: 4718502. doi: 10.1093.
    >> Share

  35. KURIAN AW, Bondarenko I, Jagsi R, Friese CR, et al
    Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2017 Dec 11. pii: 4718501. doi: 10.1093.
    >> Share

  36. GLUZ O, Nitz U, Liedtke C, Christgen M, et al
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
    J Natl Cancer Inst. 2017 Dec 8. pii: 4698155. doi: 10.1093.
    >> Share

    November 2017
  37. BELKACEMI Y, Kuten A
    RE: Regional Nodal Irradiation After Breast-Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    J Natl Cancer Inst. 2017 Nov 21. pii: 4645256. doi: 10.1093.
    >> Share

  38. MEIER M, Orr N
    Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors.
    J Natl Cancer Inst. 2017;109.
    >> Share

  39. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    >> Share

  40. DESHMUKH AA, Shirvani SM, Lal L, Swint JM, et al
    Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    >> Share

  41. SCHWARZ LJ, Hutchinson KE, Rexer BN, Estrada MV, et al
    An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
    J Natl Cancer Inst. 2017;109.
    >> Share

    October 2017
  42. LAMBERTINI M, Kroman N, Ameye L, Cordoba O, et al
    Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
    J Natl Cancer Inst. 2017 Oct 26. doi: 10.1093.
    >> Share

  43. VISSCHER DW, Frank RD, Carter JM, Vierkant RA, et al
    Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
    J Natl Cancer Inst. 2017;109.
    >> Share


  44. Restarting Adjuvant Hormone Therapy Improves Breast Cancer Outcomes.
    J Natl Cancer Inst. 2017;109.
    >> Share

  45. HE W, Smedby KE, Fang F, Olsson H, et al
    Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    >> Share

  46. HERMELINK K, Buhner M, Sckopke P, Neufeld F, et al
    Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    >> Share

  47. ROBSON ME, Reiner AS, Brooks JD, Concannon PJ, et al
    Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
    J Natl Cancer Inst. 2017;109.
    >> Share

    September 2017
  48. BYRNE C, Ursin G, Martin CF, Peck JD, et al
    Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
    J Natl Cancer Inst. 2017;109.
    >> Share

    August 2017
  49. POLLACK CE, Soulos PR, Herrin J, Xu X, et al
    The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    >> Share

  50. SCHMIDT MK, van den Broek AJ, Tollenaar RA, Smit VT, et al
    Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    J Natl Cancer Inst. 2017;109.
    >> Share

  51. GINGRAS I, Holmes E, De Azambuja E, Nguyen DH, et al
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    J Natl Cancer Inst. 2017;109.
    >> Share

    July 2017
  52. SHAFAEE MN, Ellis MJ
    Breast Cancer Patient-Derived Xenografts: Pros, Cons, and Next Steps.
    J Natl Cancer Inst. 2017;109.
    >> Share

  53. WU X, Ye Y, Barcenas CH, Chow WH, et al
    Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    J Natl Cancer Inst. 2017;109.
    >> Share

  54. ROJAS PA, May M, Sequeira GR, Elia A, et al
    Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    J Natl Cancer Inst. 2017;109.
    >> Share

  55. GOETZ MP, Kalari KR, Suman VJ, Moyer AM, et al
    Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    >> Share

  56. KUCHENBAECKER KB, McGuffog L, Barrowdale D, Lee A, et al
    Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017;109.
    >> Share

    June 2017
  57. SAMANTA SK, Sehrawat A, Kim SH, Hahm ER, et al
    Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    J Natl Cancer Inst. 2016;109.
    >> Share

  58. DAVE B, Gonzalez DD, Liu ZB, Li X, et al
    Role of RPL39 in Metaplastic Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    >> Share


  59. Higher consumption of grilled, barbecued, and smoked meat linked to increased mortality risk among breast cancer survivors.
    J Natl Cancer Inst. 2017;109.
    >> Share

    May 2017
  60. KERLIKOWSKE K, Gard CC, Tice JA, Ziv E, et al
    Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    >> Share

  61. WALTER JR, Xu S, Woodruff TK
    A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    J Natl Cancer Inst. 2017;109.
    >> Share

    April 2017
  62. NOLAN E, Vaillant F, Visvader JE, Lindeman GJ, et al
    RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017 Apr 4. doi: 10.1093.
    >> Share

  63. SCHERNHAMMER ES
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    >> Share

  64. HANSEN J
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    >> Share

  65. ERREN TC, Morfeld P, Gross JV
    RE: Night Shiftwork and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    >> Share

  66. STEVENS RG
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    >> Share

  67. GARRIDO-CASTRO AC, Winer EP
    Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    J Natl Cancer Inst. 2017;109.
    >> Share

    March 2017
  68. MA R, Karthik GM, Lovrot J, Haglund F, et al
    Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells.
    J Natl Cancer Inst. 2017;109:1-14.
    >> Share

    February 2017
  69. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2016;109.
    >> Share

  70. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2016;109.
    >> Share

  71. BANEGAS MP, John EM, Slattery ML, Gomez SL, et al
    Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    J Natl Cancer Inst. 2016;109.
    >> Share

  72. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109:2-3.
    >> Share

  73. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2017;109:1-8.
    >> Share

  74. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2017;109:1-7.
    >> Share

  75. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109.
    >> Share

    January 2017
  76. PARADA H JR, Steck SE, Bradshaw PT, Engel LS, et al
    Grilled, Barbecued, and Smoked Meat Intake and Survival Following Breast Cancer.
    J Natl Cancer Inst. 2017 Jan 4. pii: djw299. doi: 10.1093.
    >> Share

  77. KOTSOPOULOS J, Huzarski T, Gronwald J, Singer CF, et al
    Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2016;109.
    >> Share

  78. HILAKIVI-CLARKE L, Warri A, Bouker KB, Zhang X, et al
    Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
    J Natl Cancer Inst. 2016;109.
    >> Share

  79. SMITH BD, Jiang J, Shih YC, Giordano SH, et al
    Cost and Complications of Local Therapies for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    >> Share

  80. PARKES EE, Walker SM, Taggart LE, McCabe N, et al
    Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    >> Share

  81. BENSE RD, Sotiriou C, Piccart-Gebhart MJ, Haanen JB, et al
    Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    >> Share

  82. MAMOUNAS EP, Liu Q, Paik S, Baehner FL, et al
    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
    J Natl Cancer Inst. 2017;109.
    >> Share

  83. HAAS JS
    The Complexity of Achieving the Promise of Precision Breast Cancer Screening.
    J Natl Cancer Inst. 2017;109.
    >> Share

  84. SHIEH Y, Eklund M, Madlensky L, Sawyer SD, et al
    Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
    J Natl Cancer Inst. 2017;109.
    >> Share


  85. Different Breast Cancer Treatment Options Vary Widely in their Cost-Effectiveness.
    J Natl Cancer Inst. 2017;109:1-2.
    >> Share

    December 2016
  86. TRAVIS RC, Balkwill A, Fensom GK, Appleby PN, et al
    Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2016;108.
    >> Share


  87. Night Shift Work and Breast Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    >> Share

    November 2016
  88. TER BRUGGE P, Kristel P, van der Burg E, Boon U, et al
    Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    >> Share

  89. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    >> Share

    October 2016
  90. MOORE SC, Matthews CE, Ou Shu X, Yu K, et al
    Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    J Natl Cancer Inst. 2016;108.
    >> Share

  91. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    >> Share

    August 2016
  92. MARTIN LJ, Huszti E, Connelly PW, Greenberg CV, et al
    RE: Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points.
    J Natl Cancer Inst. 2016;108.
    >> Share

  93. TOOMEY S, Eustace AJ, Pritzker LB, Pritzker KP, et al
    RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    >> Share

  94. SCHMIDT C
    Mammaprint Reveals Who Can Skip Chemotherapy for Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    >> Share

    June 2016
  95. FILLON M
    Continuing To Smoke After Breast Cancer Diagnosis Lowers Survival Rate.
    J Natl Cancer Inst. 2016;108.
    >> Share

    April 2016
  96. AZVOLINSKY A
    Unraveling How Obesity Fuels Cancer.
    J Natl Cancer Inst. 2016;108.
    >> Share

  97. JENKS S
    Digital Imaging of the Breast: Is a Synthetic View Better?
    J Natl Cancer Inst. 2016;108.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016